Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 2
1(25.0%)
Phase 4
1(25.0%)
4Total
N/A(2)
Phase 2(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04586348Phase 4Active Not Recruiting

Prenatal Iodine Supplementation and Early Childhood Neurodevelopment

Role: collaborator

NCT01240057Phase 2Completed

Tracheal Occlusion To Accelerate Lung Growth (TOTAL) Trial for Severe Pulmonary Hypoplasia

Role: collaborator

NCT00763737Not ApplicableCompleted

Fetal Surgery for Moderate Left Sided Congenital Diaphragmatic Hernia.

Role: collaborator

NCT01247753Not ApplicableCompleted

Walking Exercise and Nutrition to Reduce Diabetes Risk for You (WENDY)

Role: collaborator

All 4 trials loaded